Hostname: page-component-7b7567c8c-z4zkx Total loading time: 0 Render date: 2026-11-17T14:35:36.903Z Has data issue: false hasContentIssue false

Health technology assessment in Switzerland

Published online by Cambridge University Press:  01 July 2009

Pedro Koch
Affiliation:
Viterio-Schweiz
Julian Schilling
Affiliation:
Travel Clinic Zürich
Marlène Läubli
Affiliation:
Swiss Federal Office of Public Health
Florian Mitscherlich
Affiliation:
ICHI GmbH
Dieter Melchart
Affiliation:
Zentrum für naturheilkundliche Forschung der II, Med. Klinik und Poliklinik der Technischen Universität München
Sergio Bellucci
Affiliation:
TA-Swiss
Rights & Permissions [Opens in a new window]

Abstract

Objectives and Methods: To review Switzerland's mixed public and private healthcare system with regard to health technology assessment (HTA).

Results: In the past, remarkable work in HTA was done. Accomplishments include the following: (i) Switzerland became an early member of the International Network of Agencies for Health Technology Assessment. (ii) HTA has its legal bases in terms of effectiveness, appropriateness, and efficiency. (iii) The federal law allows the introduction of new technologies for a limited time for evaluation. (iv) A Swiss Network for Health Technology Assessment was established. In 2004, federal HTA activities moved from the Swiss Federal Office “of Social Security” to the one for “Public Health.” The Office mainly mandates, manages, and coordinates evaluations attached to its prevention and intervention sections in the fields of AIDS, illegal drugs, and legal drugs.

Conclusions: Because of the absence of a governmental institution assessing and reporting on new health technologies, private and for profit organizations became more important for the decision-making processes. In a regulated market, the implications may be crucial for the public health.

Information

Type
General Essays
Copyright
Copyright © Cambridge University Press 2009